Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
17.43
+0.36 (2.08%)
At close: Oct 21, 2025, 4:00 PM EDT
17.50
+0.07 (0.40%)
After-hours: Oct 21, 2025, 5:53 PM EDT

Avalo Therapeutics Market Cap

Avalo Therapeutics has a market cap or net worth of $229.25 million as of October 21, 2025. Its market cap has increased by 2,239.24% in one year.

Market Cap
229.25M
Enterprise Value
125.61M
1-Year Change
2,239.24%
Ranking
Category
Stock Price
$17.43

Market Cap Chart

Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $229.25M, an increase of 564.48%. That is a compound annual growth rate of 20.98%.

History

DateMarket Cap% Change
Oct 20, 2025224.60M190.93%
Dec 31, 202477.20M957.53%
Dec 29, 20237.30M-84.60%
Dec 30, 202247.40M-75.17%
Dec 31, 2021190.90M-3.49%
Dec 31, 2020197.80M-16.79%
Dec 31, 2019237.70M80.35%
Dec 31, 2018131.80M58.03%
Dec 29, 201783.40M917.07%
Dec 30, 20168.20M-71.63%
Dec 31, 201528.90M-16.23%
Nov 13, 201534.50M-
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition